Alliance Pharma plc (APH) — Long-term Investment Intensity

Latest as of December 2017: 0.4%

Alliance Pharma plc (APH) has a Long-term Investment Intensity of 0.4% as of December 2017. Long-term investments of GBX1.48 Million represent 0.4% of total assets of GBX336.48 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Alliance Pharma plc liquidity resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.4%
LT Investments / Total Assets

Long-term Investments

GBX1.48 Million
GBX

Total Assets

GBX336.48 Million
GBX

Country

UK
LSE

Alliance Pharma plc Long-term Investment Intensity (2013–2017)

This chart shows how Alliance Pharma plc's Long-term Investment Intensity has evolved across 5 annual periods from 2013 to 2017. As of December 2017, the intensity stands at 0.4%, reflecting long-term investments of GBX1.48 Million against total assets of GBX336.48 Million GBX. For the complete balance sheet picture, see Alliance Pharma plc (APH) total assets.

Annual Long-term Investment Intensity for Alliance Pharma plc (2013–2017)

The table below presents the year-by-year Long-term Investment Intensity for Alliance Pharma plc from 2013 to 2017, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read how much debt does Alliance Pharma plc carry for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (GBX) Total Assets Change (pp)
2017 0.4% GBX1.48 Million GBX336.48 Million ▼ 0.0 pp
2016 0.5% GBX1.46 Million GBX320.74 Million ▼ 0.0 pp
2015 0.5% GBX1.47 Million GBX292.19 Million ▼ -0.7 pp
2014 1.2% GBX1.27 Million GBX107.87 Million ▲ +0.3 pp
2013 0.9% GBX976.00K GBX106.99 Million
pp = percentage points